Knewz on MSN
Study reveals risks of weight-loss drugs
Millions of people aiming for weight loss might find themselves needing to stay on fat-jabbing medications for life, experts ...
Wegovy is now available as a daily pill, but experts say strict dosing schedules and more intense side effects may not make it a better option than the injection.
The FDA is requiring updated labeling for tranexamic acid injection to emphasize the risk of serious harm, including death, if administered incorrectly via spinal injection. Tranexamic acid injection ...
Researchers believe nearly 25,000 hospital visits occurred, mostly due to gastrointestinal complications Getty A new study analyzed how often people develop severe side effects after taking ...
Discontinuing obesity medicines often means the weight comes back and people lose the cardiovascular and metabolic benefits ...
2don MSN
What obesity drugmakers see next in the market: More pills, easier access and drug combinations
CNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers at the annual JPMorgan Healthcare Conference in San Francisco.
New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...
Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results